Your browser doesn't support javascript.
loading
Prevalence and impact of recreational drug use in patients with acute cardiovascular events.
Pezel, Théo; Dillinger, Jean-Guillaume; Trimaille, Antonin; Delmas, Clément; Piliero, Nicolas; Bouleti, Claire; Pommier, Thibaut; El Ouahidi, Amine; Andrieu, Stéphane; Lattuca, Benoit; Rossanaly Vasram, Reza; Fard, Damien; Noirclerc, Nathalie; Bonnet, Guillaume; Goralski, Marc; Elbaz, Meyer; Deney, Antoine; Schurtz, Guillaume; Docq, Clemence; Roubille, Francois; Fauvel, Charles; Bochaton, Thomas; Aboyans, Victor; Boccara, Franck; Puymirat, Etienne; Batisse, Anne; Steg, Gabriel; Vicaut, Eric; Henry, Patrick.
Afiliação
  • Pezel T; Department of Cardiology, Hôpital Lariboisière, Assistance Publique - Hopitaux de Paris, Université Paris Cité, INSERM U 942, Paris, France.
  • Dillinger JG; Department of Cardiology, Hôpital Lariboisière, Assistance Publique - Hopitaux de Paris, Université Paris Cité, INSERM U 942, Paris, France.
  • Trimaille A; Department of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France.
  • Delmas C; Intensive Cardiac Care Unit, University Hospital of Rangueil, Toulouse, France.
  • Piliero N; Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France.
  • Bouleti C; Cardiology, University of Poitiers, Clinical Investigation Center (CIC) INSERM 1402, Poitiers University Hospital, Poitiers, France.
  • Pommier T; University Hospital Centre Dijon, Dijon, Bourgogne, France.
  • El Ouahidi A; Department of Cardiology, University Hospital of Brest, Brest, France.
  • Andrieu S; Hôpital Henri Duffaut, Avignon, France.
  • Lattuca B; Cardiology, Centre Hospitalier Universitaire de Nîmes, Montpellier University, Nimes, France.
  • Rossanaly Vasram R; Department of Cardiology, Felix-Guyon University Hospital, Saint-Denis, France.
  • Fard D; Intensive Cardiac Care Unit, Hopital Henri Mondor, Creteil, France.
  • Noirclerc N; Centre Hospitalier Annecy Genevois, Epagny Metz-Tessy, Rhône-Alpes, France.
  • Bonnet G; Assistance Publique Hopitaux de Marseille, Aix Marseille Univ, INSERM, INRAE, C2VN, Marseille, Provence-Alpes-Côte d'Azu, France.
  • Goralski M; Unité de Recherche Clinique, Groupe hospitalier Lariboisiere Fernand-Widal, Paris, Île-de-France, France.
  • Elbaz M; Centre Hospitalier d'Orleans, Orléans, France.
  • Deney A; Intensive Cardiac Care Unit, University Hospital of Rangueil, Toulouse, France.
  • Schurtz G; University Hospital Centre Toulouse, Toulouse, Midi-Pyrénées, France.
  • Docq C; Cardiology, CHRU Lille, Lille, France.
  • Roubille F; Department of Cardiology, University Hospital of Lille, Lille, France.
  • Fauvel C; Cardiology Department, INI-CRT, CHU de Montpellier, PhyMedExp, Université de Montpellier, INSERM, CNRS, Montpellier, France.
  • Bochaton T; Rouen University Hospital, INSERM EnVI 1096, Rouen, France.
  • Aboyans V; Intensive Cardiological Care Division, Louis Pradel Hospital, Hospices Civils de Lyon, Lyon, France.
  • Boccara F; Department of Cardiology, Dupuytren University Hospital and Inserm 1094, Limoges, France.
  • Puymirat E; Cardiology, Sorbonne Université, GRC n°22, C²MV, Inserm UMR_S 938, Centre de Recherche Saint-Antoine, Institut Hospitalo-Universitaire de Cardio-métabolisme et Nutrition (ICAN), Assistance Publique-Hôpitaux de Paris, Hôpital Saint Antoine Service de Cardiologie, Paris, France.
  • Batisse A; Cardiologie, Hôpital européen Georges-Pompidou, Paris, France.
  • Steg G; Centre d'évaluation et d'information sur la pharmacodépendence de Paris, GH Lariboisiere Fernand-Widal, Paris, Île-de-France, France.
  • Vicaut E; Cardiology, Université Paris-Cité, Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, and Institut Universitaire de France, PARIS, France.
  • Henry P; Unité de Recherche Clinique, Groupe hospitalier Lariboisiere Fernand-Widal, Paris, Île-de-France, France.
Heart ; 109(21): 1608-1616, 2023 Oct 12.
Article em En | MEDLINE | ID: mdl-37582633
ABSTRACT

OBJECTIVE:

While recreational drug use is a risk factor for cardiovascular events, its exact prevalence and prognostic impact in patients admitted for these events are not established. We aimed to assess the prevalence of recreational drug use and its association with in-hospital major adverse events (MAEs) in patients admitted to intensive cardiac care units (ICCU).

METHODS:

In the Addiction in Intensive Cardiac Care Units (ADDICT-ICCU) study, systematic screening for recreational drugs was performed by prospective urinary testing all patients admitted to ICCU in 39 French centres from 7 to 22 April 2021. The primary outcome was prevalence of recreational drug detection. In-hospital MAEs were defined by death, resuscitated cardiac arrest, or haemodynamic shock.

RESULTS:

Of 1499 consecutive patients (63±15 years, 70% male), 161 (11%) had a positive test for recreational drugs (cannabis 9.1%, opioids 2.1%, cocaine 1.7%, amphetamines 0.7%, 3,4-methylenedioxymethamphetamine (MDMA) 0.6%). Only 57% of these patients declared recreational drug use. Patients who used recreational drugs exhibited a higher MAE rate than others (13% vs 3%, respectively, p<0.001). Recreational drugs were associated with a higher rate of in-hospital MAEs after adjustment for comorbidities (OR 8.84, 95% CI 4.68 to 16.7, p<0.001). After adjustment, cannabis, cocaine, and MDMA, assessed separately, were independently associated with in-hospital MAEs. Multiple drug detection was frequent (28% of positive patients) and associated with an even higher incidence of MAEs (OR 12.7, 95% CI 4.80 to 35.6, p<0.001).

CONCLUSION:

The prevalence of recreational drug use in patients hospitalised in ICCU was 11%. Recreational drug detection was independently associated with worse in-hospital outcomes. CLINICAL TRIAL REGISTRATION NCT05063097.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article